share_log

Walgreens Boots Alliance | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Walgreens Boots Alliance Holdings LLC(13.2%),WBA Investments, Inc.(13.2%), etc.

ウォルグリーン・ブーツ・アライアンス | SC 13D/A:大量保有報告書(訂正)-Walgreens Boots Alliance Holdings LLC(13.2%),WBA Investments, Inc.(13.2%)など

SEC announcement ·  02/09 09:22
Moomoo AIのまとめ
On February 7, 2024, Walgreens Boots Alliance Holdings LLC (WBA Holdings), a subsidiary of Walgreens Boots Alliance, Inc. (WBA), sold a significant portion of its shares in Cencora, Inc. The transaction involved the sale of 4 million shares in an unregistered block trade under Rule 144 of the Securities Act of 1933, representing approximately 13.2% of Cencora's outstanding common stock. Concurrently, WBA Holdings and Cencora entered into a share repurchase agreement, where Cencora repurchased 212,395 shares from WBA Holdings at the same price per share as the block trade. The proceeds from these transactions are intended for WBA to pay down debt and for general corporate purposes, aligning with WBA's strategy to optimize its capital efficiency within its retail pharmacy framework. This move is part of WBA's ongoing review of its strategic and capital allocation priorities, which may lead to further sales of Cencora stock. The transactions were completed with the legal counsel of Cleary Gottlieb Steen & Hamilton LLP and Morgan, Lewis & Bockius LLP.
On February 7, 2024, Walgreens Boots Alliance Holdings LLC (WBA Holdings), a subsidiary of Walgreens Boots Alliance, Inc. (WBA), sold a significant portion of its shares in Cencora, Inc. The transaction involved the sale of 4 million shares in an unregistered block trade under Rule 144 of the Securities Act of 1933, representing approximately 13.2% of Cencora's outstanding common stock. Concurrently, WBA Holdings and Cencora entered into a share repurchase agreement, where Cencora repurchased 212,395 shares from WBA Holdings at the same price per share as the block trade. The proceeds from these transactions are intended for WBA to pay down debt and for general corporate purposes, aligning with WBA's strategy to optimize its capital efficiency within its retail pharmacy framework. This move is part of WBA's ongoing review of its strategic and capital allocation priorities, which may lead to further sales of Cencora stock. The transactions were completed with the legal counsel of Cleary Gottlieb Steen & Hamilton LLP and Morgan, Lewis & Bockius LLP.
2024年2月7日、Walgreens Boots Alliance Holdings LLC(WBA Holdings)は、Walgreens Boots Alliance, Inc.(WBA)の子会社として、Cencora, Inc.の株式の重要な部分を売却しました。この取引は、1933年の証券法144条に基づく未登録ブロックトレードで、400万株を取引し、Cencoraの発行済み普通株式の約13.2%を占めます。同時に、WBA HoldingsとCencoraは株式買戻し契約に調印し、CencoraがWBA Holdingsから1株当たり同じ価格で212,395株を買い戻しました。これら...すべて展開
2024年2月7日、Walgreens Boots Alliance Holdings LLC(WBA Holdings)は、Walgreens Boots Alliance, Inc.(WBA)の子会社として、Cencora, Inc.の株式の重要な部分を売却しました。この取引は、1933年の証券法144条に基づく未登録ブロックトレードで、400万株を取引し、Cencoraの発行済み普通株式の約13.2%を占めます。同時に、WBA HoldingsとCencoraは株式買戻し契約に調印し、CencoraがWBA Holdingsから1株当たり同じ価格で212,395株を買い戻しました。これらの取引からの収益は、WBAが債務を返済し、一般的な企業目的に充てるために意図され、小売り薬局枠組み内で資本効率を最適化するための戦略に一致します。この動きは、WBAが戦略と資本割り当ての優先事項を継続的に見直している一環であり、Cencora株式のさらなる売却につながる可能性があります。この取引は、Cleary Gottlieb Steen & Hamilton LLPおよびMorgan, Lewis & Bockius LLPの法律顧問のもとで完了されました。
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報